Calprotectin in Chronic Inflammatory Demyelinating Polyneuropathy and Variants-A Potential Novel Biomarker of Disease Activity.

Stascheit F, Hotter B, Klose S, Meisel C, Meisel A, Klehmet J

Open source

DOI
10.3389/fneur.2021.723009
Published
2021
Container
Frontiers in neurology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fneur.2021.723009,
  title = {Calprotectin in Chronic Inflammatory Demyelinating Polyneuropathy and Variants-A Potential Novel Biomarker of Disease Activity.},
  author = {Stascheit F and Hotter B and Klose S and Meisel C and Meisel A and Klehmet J},
  year = {2021},
  journal = {Frontiers in neurology},
  doi = {10.3389/fneur.2021.723009},
  url = {https://doi.org/10.3389/fneur.2021.723009}
}

RIS

TY  - JOUR
TI  - Calprotectin in Chronic Inflammatory Demyelinating Polyneuropathy and Variants-A Potential Novel Biomarker of Disease Activity.
AU  - Stascheit F
AU  - Hotter B
AU  - Klose S
AU  - Meisel C
AU  - Meisel A
AU  - Klehmet J
PY  - 2021
JO  - Frontiers in neurology
DO  - 10.3389/fneur.2021.723009
UR  - https://doi.org/10.3389/fneur.2021.723009
ER  - 

APA

F, S., B, H., S, K., C, M., A, M., & J, K. (2021). Calprotectin in Chronic Inflammatory Demyelinating Polyneuropathy and Variants-A Potential Novel Biomarker of Disease Activity.. Frontiers in neurology. https://doi.org/10.3389/fneur.2021.723009

Source records